FDA approves a new artificial retinal implant to restore limited vision in blinded patients.
Tag: retinitis pigmentosa
Hope For Treatment Of Hearing Loss With Usher Syndrome III
A new study published in the July 11 issue of the Journal of Neuroscience details the development of the first mouse model engineered to carry the most common mutation in Usher syndrome III causative gene (Clarin-1) in North America. Further, the resea…
Gene Therapy in Ophthalmology Update 6: First-Ever Clinical Trial for the Autosomal Recessive Form of Retinitis Pigmentosa (arRP) is Underway
It has been difficult keeping up with the changing world of gene therapy in ophthalmology, but thanks to the Foundation Fighting Blindness, I learned yesterday about this new, and first clinical study for treating a rare form of retinitis pigmentosa, u…
Neurotech’s NT-501 Implant Demonstrates Statistically Significant Photoreceptor Preservation In Patients With Retinal Degenerative Disease
Neurotech Pharmaceuticals, Inc., today announced that, as reported in Investigative Ophthalmology & Visual Science (April, 2011, Vol…
Positive News for Drug to Treat Leber Congenital Amaurosis and Retinitis Pigmentosa
QLT Inc. today announced that QLT091001, an oral synthetic retinoid, has received positive opinions for two distinct Orphan Drug Designations by the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) for the treatment of the inherited retinal degenerative…
The Use of Gene Therapy in Treating Retinitis Pigmentosa and Dry AMD
A short while ago, I received a message from someone I did not know, who said that he enjoyed the writeups on my online Journal and was wondering if I might be interested in writing about the use of gene therapy as an approach to vision restoration. Si…